Biovaxys Technology Corp (5LB0) Stock Price & News

All values in CAD	Oct 2024	Jan 2025	Apr 2025	Jul 2025
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	1.50K	32.95K	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	1.20M	1.03M	1.08M	859.08K
Operating expense	1.49M	1.14M	1.22M	859.08K
Total operating expenses	1.49M	1.14M	1.22M	859.08K
Operating income	-1.49M	-1.14M	-1.22M	-859.08K
Other non operating income	-8.90K	-68.18K	-67.98K	-50.97K
EBT including unusual items	-2.74M	-1.07M	-1.32M	-910.06K
EBT excluding unusual items	-1.50M	-1.25M	-1.30M	-910.06K
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-2.74M	-1.07M	-1.32M	-910.06K
Net profit margin	-	-	-	-
Earnings per share	-	-	-	-
Interest and investment income	-	-	-	-
Interest expense	-	-	-	-
Net interest expenses	-	-	-	-
Depreciation and amortization charges	-	-	-	-
EBITDA	-	-	-	-
Gain or loss from assets sale	-	-	-	-

Finance